3,520 Shares in Astera Labs, Inc. $ALAB Purchased by Nicholas Investment Partners LP

Nicholas Investment Partners LP acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 3,520 shares of the company’s stock, valued at approximately $1,700,000.

Several other institutional investors and hedge funds also recently bought and sold shares of ALAB. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs in the 2nd quarter valued at about $25,000. Johnson Financial Group Inc. purchased a new stake in shares of Astera Labs in the second quarter worth approximately $43,000. Bell Investment Advisors Inc acquired a new stake in shares of Astera Labs during the second quarter worth approximately $43,000. Reflection Asset Management acquired a new stake in shares of Astera Labs during the fourth quarter worth approximately $25,000. Finally, Trifecta Capital Advisors LLC purchased a new position in Astera Labs during the second quarter valued at approximately $79,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the sale, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 419,244 shares of company stock valued at $163,135,169 in the last three months. 10.40% of the stock is currently owned by company insiders.

Astera Labs Stock Down 2.6%

ALAB stock opened at $277.53 on Tuesday. The company has a market capitalization of $48.15 billion, a price-to-earnings ratio of 137.39 and a beta of 3.84. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a 50 day moving average of $350.46 and a two-hundred day moving average of $246.41.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ALAB. Needham & Company LLC upped their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. JPMorgan Chase & Co. lifted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Roth Capital restated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Evercore reaffirmed an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Finally, Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.